Atorvastatin reduced coronary and stroke events in patients with hypertension and without dyslipidemia: COMMENTARY

Simon, Joel A.
November 2003
ACP Journal Club;Nov/Dec2003, Vol. 139 Issue 3, p57
Academic Journal
Except for the Antihypertensivc and Lipid-Lowering Heart Attack Trial (ALLHAT), which was non-blinded and suffered from the frequent use of statins among participants who were allocated to placebo, Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA) has joined other primary and secondary coronary heart disease (CHD) prevention studies showing that lowering low-density lipoprotein cholesterol with statins prevents CHD events among persons at higher CHD risk. Primary CHD-prevention statins trials, including ASCOT-LLA, when taken together have additionally shown a trend toward lower all-cause mortality. Although benefit correlates with the magnitude of cholesterol lowering, statins have important effects on inflammatory markers, plaque stabilization, nitric oxide production, and thrombosis that probably add to their effectiveness.


Related Articles

  • Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre rando...  // Current Medical Literature: Stroke Review;2003, Vol. 7 Issue 3, p85 

    Reports on a study which set out to assess the benefits of cholesterol lowering in the primary prevention of coronary heart disease in hypertensive patients who are not conventionally deemed dyslipidemic. Reduction in major end points with atorvastatin; Need for a radical rethink on the...

  • Miracle or mirage? Learner, Sue // Nursing Standard;8/1/2007, Vol. 21 Issue 47, p18 

    More than two million people in the UK are taking statins to reduce their cholesterol. But some doctors claim that they can cause affective disorders.

  • The National Cholesterol Eduction Program. Cleeman, James I.; Lenfant, Claude // JAMA: Journal of the American Medical Association;12/23/98, Vol. 280 Issue 24, p2099 

    Discusses the National Cholesterol Education Program (NCEP) from the United States National Heart, Lung, and Blood Institute. Efforts to promote improved prevention and treatment of cardiovascular disease; Clinical trails which have provided conclusive evidence for the benefits of cholesterol...

  • Coronary Prevention Group calls for cholesterol testing for all.  // BMJ: British Medical Journal (International Edition);3/4/89, Vol. 298 Issue 6673, p552 

    Reports the call of Coronary Prevention Group for cholesterol testing in Great Britain. Strategy of preventing coronary heart disease; Need for assessment of risk factors of the disease; Advice for patients with high cholesterol concentrations.

  • Knowledge assessment regarding secondary prevention of coronary heart disease- a multi centre survey. Matthias, Anne Thushara; Lokunarangoda, Niroshan C.; Ekanayaka, Ruvan // BMC Medical Education;2014, Vol. 14 Issue 1, p1 

    Background Cardiovascular Disease (CVD) is a major cause of mortality worldwide. Control and reduction of cardiovascular risk factors such as elevated blood pressure, high cholesterol levels, excess of body weight, smoking and lack of exercise can contribute to a reduction of CVD mortality....

  • The role of Coenzyme Q10 in statin-associated myopathy. Kalra, Sanjay; Agrawal, Navneet; Kalra, Bharti; Sharma, Amit; Kamboj, Ritu // Electronic Physician;2009, Vol. 1, p2 

    Statins, or 3-hydroxyl-3-methylglutaryl coenzyme HMG-CoA reductase inhibitors, are cholesterol-lowering drugs which are frequently used in the primary and secondary prevention of coronary artery disease. Current research and recommendations support and encourage more extensive use of these...

  • Patients 'exercise' their right to manage cholesterol. Petersen, Carolyn // Managed Healthcare;Jan1999, Vol. 9 Issue 1, p52 

    Focuses on an alternative approach in managing the cost of high cholesterol in the United States. Blood cholesterol level management as one way of reducing the incidence of coronary heart disease (CHD); Cost-effectiveness of various dosages of a single therapeutic; Exercise as an important key...

  • Prospects for preventing heart disease: Population based approaches offer a cost effective way of reducing risk. Leeder, Stephen; Gliksman, Michael // BMJ: British Medical Journal (International Edition);11/3/90, Vol. 301 Issue 6759, p1004 

    Focuses on the preventive measures for coronary heart disease. Evaluation of mortality rate caused by the disease; Measurement of blood pressure and total serum cholesterol concentration; Contribution of cigarette smoking on the development of the disease.

  • Lower patients' cholesterol now. Oliver, Michael; Poole-Wilson, Philip // BMJ: British Medical Journal (International Edition);5/20/95, Vol. 310 Issue 6990, p1280 

    Presents clinical trial evidence to the principle that the risk of coronary heart disease and total mortality can be reduced by lowering plasma cholesterol concentrations. Principles of lipid hypothesis; Questions on cholesterol reduction; Favorable results from scandinavian studies on...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics